TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2029015

Group type: EXPERIMENTAL
Intervention: 24-hour esophageal pH monitoring
Number of subjects: 100

Group type: COMPARATOR
Intervention: Esophageal manometry
Number of subjects: 100

Group type: COMPARATOR
Intervention: Acid perfusion test
Number of subjects: 100

Group type: COMPARATOR
Intervention: Edrophonium test
Number of subjects: 100
Study: 6941445

Group type: EXPERIMENTAL
Intervention: 2 g of tinidazole administered 8-15 hours before the abortion
Number of subjects: 212

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 212
Study: 31321428

Group type: EXPERIMENTAL
Intervention: Breakfast of oats and milk (431 kcal; 65 g carbohydrate, 11 g fat, 19 g protein) followed by rest (BR)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Breakfast before exercise (BE; 60 min cycling at 50 % peak power output)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Overnight fasting before exercise (FE)
Number of subjects: 12
Study: 29241508

Group type: EXPERIMENTAL
Intervention: Technology-based intervention using multiple languages
Number of subjects: 0
Study: 25580775

Group type: EXPERIMENTAL
Intervention: Lobeglitazone (0.5mg)
Number of subjects: 253

Group type: COMPARATOR
Intervention: Pioglitazone (15mg)
Number of subjects: 253
Study: 24304626

Group type: EXPERIMENTAL
Intervention: Reflexology therapy for 30 minutes on feet, hands, and ears for 5 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no reflexology therapy)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Reflexology therapy
Number of subjects: 60
Study: 21861639

Group type: EXPERIMENTAL
Intervention: MGCSH mixed with PRP
Number of subjects: 16

Group type: COMPARATOR
Intervention: Collagen resorbable plug
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 16
Study: 19609242

Group type: EXPERIMENTAL
Intervention: protamine-protected mRNA vaccination with KLH
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: protamine-protected mRNA vaccination without KLH
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: protamine-protected mRNA vaccination
Number of subjects: 21
Study: 17464992

Group type: EXPERIMENTAL
Intervention: Clevudine 30 mg once daily for 24 weeks
Number of subjects: 243

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 243
Study: 16236838

Group type: EXPERIMENTAL
Intervention: Formoterol (Turbuhaler), 24 microg bid for 4 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Budesonide (Turbuhaler), 400 microg bid for 4 weeks (gold standard comparison)
Number of subjects: 15
Study: 11296078

Group type: EXPERIMENTAL
Intervention: IV ketorolac (0.5 to 1 mg/kg) and IV fluids
Number of subjects: 51
Study: 9693699

Group type: EXPERIMENTAL
Intervention: Preterm infants
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Caregivers' report
Number of subjects: 67
Study: 7841087

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no verapamil)
Number of subjects: 0
Study: 3419942

Group type: EXPERIMENTAL
Intervention: Multisensory teaching method using anatomic dolls
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Cognitive‐perceptual teaching method using two-dimensional drawings
Number of subjects: 159

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 159
Study: 31063421

Group type: EXPERIMENTAL
Intervention: ULRI‐IE/IT
Number of subjects: 23

Group type: COMPARATOR
Intervention: Unassisted fluoroscopy
Number of subjects: 23
Study: 29206631

Group type: EXPERIMENTAL
Intervention: Extrafine beclomethasone (HFA-QVAR)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Non-extrafine beclomethasone (HFA-Clenil)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Fluticasone (HFA-Flixotide)
Number of subjects: 43
Study: 25735565

Group type: EXPERIMENTAL
Intervention: Socket augmentation
Number of subjects: 38

Group type: COMPARATOR
Intervention: Non-augmented sockets
Number of subjects: 38
Study: 24161288

Group type: EXPERIMENTAL
Intervention: Group A: MP (2 mg/kg) after lidocaine (0.6 mg/kg) with a tourniquet with arm down (venous engorgement)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Group B: MP after lidocaine with a tourniquet with arm up (venous gravity drainage)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Group C: MP with a tourniquet with arm down
Number of subjects: 140

Group type: COMPARATOR
Intervention: Group D: Control group received MP only (with no tourniquet)
Number of subjects: 140
Study: 21804435

Group type: EXPERIMENTAL
Intervention: Peroxide-based system (CIBA Vision ClearCare)
Number of subjects: 30

Group type: COMPARATOR
Intervention: System preserved with Polyquad and Aldox (Alcon OPTI-FREE RepleniSH)
Number of subjects: 30
Study: 19698996

Group type: EXPERIMENTAL
Intervention: 480 mg caffeine
Number of subjects: 98

Group type: COMPARATOR
Intervention: Caffeine-free solution
Number of subjects: 98
Study: 17259128

Group type: EXPERIMENTAL
Intervention: Combined use of methotrexate and mifepristone
Number of subjects: 1706

Group type: COMPARATOR
Intervention: Exclusive use of methotrexate
Number of subjects: 1706
Study: 15388539

Group type: EXPERIMENTAL
Intervention: Linear heading drill with 20 balls at 88.71 km/h (55 mph)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Rotational heading drill with 20 balls at 88.71 km/h (55 mph)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Simulated rotational heading drill
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control group (no heading drill)
Number of subjects: 4
Study: 10978039

Group type: EXPERIMENTAL
Intervention: Piracetam (2400 mg twice daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 8992436

Group type: EXPERIMENTAL
Intervention: Periconceptional multivitamin supplementation including 0.8 mg folic acid
Number of subjects: 5502

Group type: COMPARATOR
Intervention: Placebo-like trace-element control group
Number of subjects: 5502
Study: 1591140

Group type: EXPERIMENTAL
Intervention: Triamterene
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amiloride
Number of subjects: 0

Group type: COMPARATOR
Intervention: Frusemide or Hydrochlorothiazide
Number of subjects: 0
Study: 6375276

Group type: EXPERIMENTAL
Intervention: 25 mg hydrochlorothiazide twice daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 30836396

Group type: EXPERIMENTAL
Intervention: Off-pump beating-heart surgery
Number of subjects: 736

Group type: COMPARATOR
Intervention: On-pump beating-heart surgery
Number of subjects: 736
Study: 28600473

Group type: EXPERIMENTAL
Intervention: Cidofovir (n = 30)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Imiquimod (n = 33)
Number of subjects: 167
Study: 25890835

Group type: EXPERIMENTAL
Intervention: 1500 IU hCG 6 days post TAI (D6)
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: 1500 IU hCG 4 days post TAI (D4)
Number of subjects: 406

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: 1500 IU hCG 6 days post TAI (D6) during summer
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: 1500 IU hCG 4 days post TAI (D4) during summer
Number of subjects: 406

Group type: COMPARATOR
Intervention: Control group (CON) during summer
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: 1500 IU hCG 6 days post TAI (D6) during winter
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: 1500 IU hCG 4 days post TAI (D4) during winter
Number of subjects: 406

Group type: COMPARATOR
Intervention: Control group (CON) during winter
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: 1500 IU hCG 4 days post TAI (D4) in primiparous cows
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: 1500 IU hCG 6 days post TAI (D6) in primiparous cows
Number of subjects: 406

Group type: COMPARATOR
Intervention: Control group (CON) in primiparous cows
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: 1500 IU hCG 6 days post TAI (D6) in multiparous cows
Number of subjects: 406

Group type: COMPARATOR
Intervention: Control group (CON) in multiparous cows
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: 1500 IU hCG 4 days post TAI (D4) in multiparous cows
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Treatment groups (D4 and D6)
Number of subjects: 406
Study: 23885991

Group type: EXPERIMENTAL
Intervention: Glycomacropeptide (GMP)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Beta‐lactoglobulin (ß‐lac)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Colostrum whey protein concentrate (WPC)
Number of subjects: 18

Group type: COMPARATOR
Intervention: WPC control
Number of subjects: 18
Study: 22084264

Group type: EXPERIMENTAL
Intervention: Patient activation and physician decision support tool
Number of subjects: 4105

Group type: EXPERIMENTAL
Intervention: High use of patient activation kiosk
Number of subjects: 4105

Group type: EXPERIMENTAL
Intervention: High use of decision support tools by physicians
Number of subjects: 4105
Study: 19554711

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Subgingival ultrasound only (Control)
Number of subjects: 58
Study: 17713337

Group type: EXPERIMENTAL
Intervention: Fluoride varnish (Duraphat) applied twice-yearly at school for 26 months
Number of subjects: 664

Group type: COMPARATOR
Intervention: Control group (no fluoride varnish)
Number of subjects: 664
Study: 14604835

Group type: EXPERIMENTAL
Intervention: Ultrasonography for detection and surveillance of small abdominal aortic aneurysms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early, open, elective surgery for small aneurysms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Open or endovascular surgery for aneurysms exceeding 5.5 cm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New treatments to reduce expansion rate by >50%
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statins as a proposed treatment
Number of subjects: 0
Study: 12439840

Group type: EXPERIMENTAL
Intervention: Steroid treatment for 6 months
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Immunosuppressive drugs
Number of subjects: 18

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Steroids and azathioprine
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Steroids and cyclophosphamide
Number of subjects: 18
Study: 10353328

Group type: EXPERIMENTAL
Intervention: 0.3 mg folic acid
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 120 mg vitamin B6
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Combination of 0.3 mg folic acid and 120 mg vitamin B6
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 0.6 mg folic acid
Number of subjects: 4
Study: 7477145

Group type: EXPERIMENTAL
Intervention: Lumpectomy alone
Number of subjects: 2105

Group type: EXPERIMENTAL
Intervention: Lumpectomy plus breast irradiation
Number of subjects: 2105

Group type: COMPARATOR
Intervention: Total mastectomy
Number of subjects: 2105
Study: 1934661

Group type: EXPERIMENTAL
Intervention: D + W (dipyridamole and low-dose warfarin)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (cessation of D + W)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Original treatment group (27 patients)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: New treatment group (n = 13)
Number of subjects: 48
Study: 6119937

Group type: EXPERIMENTAL
Intervention: pindolol (beta-blocker with intrinsic sympathomimetic activity)
Number of subjects: 0

Group type: COMPARATOR
Intervention: beta-blockers without intrinsic sympathomimetic activity
Number of subjects: 0
Study: 6145932

Group type: EXPERIMENTAL
Intervention: Nasal air oscillation at 8 Hz
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nasal air oscillation at 14 Hz
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nasal air oscillation at 20 Hz
Number of subjects: 0
Study: 31987567

Group type: EXPERIMENTAL
Intervention: Verum acupuncture (performed at ST34, ST36, and LR3)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Sham acupuncture (performed at three nontraditional points)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (resting for 2 minutes without treatment)
Number of subjects: 45
Study: 28800211

Group type: EXPERIMENTAL
Intervention: Generic dofetilide 0.5 mg
Number of subjects: 73

Group type: COMPARATOR
Intervention: Reference formulation
Number of subjects: 73
Study: 27120408

Group type: EXPERIMENTAL
Intervention: Self-gripping mesh
Number of subjects: 363

Group type: COMPARATOR
Intervention: Standard polypropylene mesh
Number of subjects: 363
Study: 24840659

Group type: EXPERIMENTAL
Intervention: Nighttime bending brace treatment
Number of subjects: 37

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 37
Study: 22339294

Group type: EXPERIMENTAL
Intervention: Physician delivering HIV/AIDS messages using a combined statistical/emotional format
Number of subjects: 0

Group type: COMPARATOR
Intervention: Minister delivering HIV/AIDS messages (not explicitly detailed in outcomes)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gain-framed and loss-framed information (not explicitly detailed in outcomes)
Number of subjects: 0
Study: 20555283

Group type: EXPERIMENTAL
Intervention: Complex Set (CS)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Traditional Set (TS)
Number of subjects: 18
Study: 18455944

Group type: EXPERIMENTAL
Intervention: Therapeutic ultrasound (US)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Sham ultrasound (sham US)
Number of subjects: 49
Study: 16454443

Group type: EXPERIMENTAL
Intervention: Patients with OSA
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (snoring persons)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Patients with OSA (male group)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Patients with OSA (female group)
Number of subjects: 36
Study: 14641839

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 546

Group type: EXPERIMENTAL
Intervention: HIV-infected children
Number of subjects: 546

Group type: COMPARATOR
Intervention: HIV-uninfected children
Number of subjects: 546

Group type: EXPERIMENTAL
Intervention: HIV positive children
Number of subjects: 546
Study: 10648325

Group type: EXPERIMENTAL
Intervention: Ketamine during propofol anesthesia (n = 10)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Saline during propofol anesthesia (n = 6)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Propofol anesthesia (Group D, n = 7)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Propofol-ketamine anesthesia (Group E, n = 8)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Awake (Group C, n = 7)
Number of subjects: 31
Study: 8690819

Group type: EXPERIMENTAL
Intervention: Epoprostenol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional therapy alone
Number of subjects: 30
Study: 2066441

Group type: EXPERIMENTAL
Intervention: Tetracycline-immobilized cross-linked collagen film (TC film) administered 4 times at 1-week intervals
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Root planing (RP) treatment
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Combination treatment (TC + RP)
Number of subjects: 16

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 16
Study: 6367861

Group type: EXPERIMENTAL
Intervention: 6 months of adjuvant chemotherapy with CMF
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: 12 months of adjuvant chemotherapy with CMF
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: 6 months of CMF preceded by local-regional x-ray therapy (XRT)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: 12 months of CMF
Number of subjects: 308

Group type: COMPARATOR
Intervention: Combined two non-XRT arms (6 months CMF and 6 months CMF with XRT)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: XRT treatment arm
Number of subjects: 308
Study: 31601357

Group type: EXPERIMENTAL
Intervention: RAFT - group cognitive-behavioural therapy (CBT) programme delivered by rheumatology tutor pairs (nurses/occupational therapists)
Number of subjects: 333

Group type: COMPARATOR
Intervention: Usual care - brief discussion of a RA fatigue self-management booklet with the research nurse
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: RAFT - group CBT programme
Number of subjects: 333

Group type: COMPARATOR
Intervention: Usual care - brief discussion of a RA fatigue self-management booklet
Number of subjects: 333
Study: 30373553

Group type: EXPERIMENTAL
Intervention: 2 L Physioneal 1.36% glucose dialysis fluid
Number of subjects: 10

Group type: COMPARATOR
Intervention: 2 L Physioneal 3.86% glucose dialysis fluid
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both glucose concentrations (1.36% and 3.86%)
Number of subjects: 10
Study: 27040693

Group type: EXPERIMENTAL
Intervention: Lower body power training (PT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lower body power training followed by 30 min of low‐intensity running (PET)
Number of subjects: 20
Study: 24527531

Group type: EXPERIMENTAL
Intervention: On-time dosing of tadalafil (10 mg/20 mg, twice a week for 8 weeks)
Number of subjects: 120

Group type: COMPARATOR
Intervention: On-demand dosing of tadalafil (10 mg/20 mg before sexual activity)
Number of subjects: 120
Study: 22205307

Group type: EXPERIMENTAL
Intervention: 1200 mg n-3 LCPUFAs as a supplement per day and a concomitant reduction in arachidonic acid intake
Number of subjects: 208

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 208
Study: 20970603

Group type: EXPERIMENTAL
Intervention: Once daily prolonged-release tacrolimus (QD)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Twice-daily tacrolimus (BID)
Number of subjects: 27
Study: 17686103

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 16366757

Group type: EXPERIMENTAL
Intervention: Caffeine 2.5 mg/kg p.o.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caffeine 5.0 mg/kg p.o.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nicotine (20 microg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (0)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caffeine and nicotine
Number of subjects: 0
Study: 11923693

Group type: EXPERIMENTAL
Intervention: Everolimus 0.75 mg bid
Number of subjects: 695

Group type: EXPERIMENTAL
Intervention: Everolimus 1.5 mg bid
Number of subjects: 695

Group type: EXPERIMENTAL
Intervention: Everolimus (both dosages)
Number of subjects: 695
Study: 9695999

Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 527

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 527
Study: 8005290

Group type: EXPERIMENTAL
Intervention: Vaginal progestin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IM progestin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dydrogesterone
Number of subjects: 0
Study: 2658177

Group type: EXPERIMENTAL
Intervention: Ranitidine (50 mg intravenously every 6 hours for 72 hours)
Number of subjects: 83

Group type: COMPARATOR
Intervention: No ranitidine treatment (control group)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Transfused patients
Number of subjects: 83
Study: 1103210

Group type: EXPERIMENTAL
Intervention: frontalis EMG biofeedback (variable frequency auditory feedback)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: passive relaxation instructions (instructions to attend to and relax muscles)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: active relaxation instructions (tensing and relaxing exercises)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: false feedback
Number of subjects: 101

Group type: COMPARATOR
Intervention: no treatment control
Number of subjects: 101
Study: 31846094

Group type: EXPERIMENTAL
Intervention: Postsurgical reconstruction
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Post-prosthetic rehabilitation
Number of subjects: 273

Group type: COMPARATOR
Intervention: Post-rhinectomy nasal defect
Number of subjects: 273

Group type: COMPARATOR
Intervention: Monocular blindness
Number of subjects: 273

Group type: COMPARATOR
Intervention: Binocular blindness
Number of subjects: 273
Study: 31318745

Group type: EXPERIMENTAL
Intervention: Mirror-aided cross-education
Number of subjects: 32

Group type: COMPARATOR
Intervention: Cross-education alone
Number of subjects: 32
Study: 28280731

Group type: EXPERIMENTAL
Intervention: Tapered implant with knife‐edge threads/nanostructured calcium‐incorporated surface (Anyridge®, Megagen)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Cylindrical implant with self‐tapping threads/sandblasted surface (EZPlus®, Megagen)
Number of subjects: 10
Study: 26537979

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Horticultural activity
Number of subjects: 90

Group type: COMPARATOR
Intervention: Educational control group
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Exercise and Horticultural activity
Number of subjects: 90
Study: 23663579

Group type: EXPERIMENTAL
Intervention: Tirofiban and warfarin combined with aspirin and clopidogrel (observation group)
Number of subjects: 505

Group type: COMPARATOR
Intervention: Aspirin and clopidogrel (control group)
Number of subjects: 505
Study: 21410840

Group type: EXPERIMENTAL
Intervention: Misoprostol moistened with normal saline solution (NSS)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Misoprostol moistened with acetic acid
Number of subjects: 179
Study: 19462302

Group type: EXPERIMENTAL
Intervention: Sublingual nicotine replacement therapy (NRT)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 211
Study: 17456856

Group type: EXPERIMENTAL
Intervention: Pelvic-floor muscle training (PFMT) regimen 2 to 3 times per week or more
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Task self-efficacy (SE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regulatory self-efficacy (SE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-efficacy scores over time
Number of subjects: 0
Study: 15647996

Group type: EXPERIMENTAL
Intervention: polyethylene‐on‐zirconia
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: CoCr‐on‐CoCr
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: alumina‐on‐alumina
Number of subjects: 225
Study: 11494629

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) consisting of conjugated equine estrogens and medroxyprogesterone acetate (MPA)
Number of subjects: 2763

Group type: COMPARATOR
Intervention: Control group (untreated women)
Number of subjects: 2763
Study: 9403148

Group type: EXPERIMENTAL
Intervention: Probabilistic reasoning task with emotionally neutral material
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Probabilistic reasoning task with emotional content
Number of subjects: 0